Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.43 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.41 |
| ▸ | PPARG | P37231 | 7/20 | 0.41 |
| ▸ | PPARD | Q03181 | 7/20 | 0.41 |
| ▸ | PPARA | Q07869 | 7/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | TLR2 | O60603 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | SLC22A6 | Q4U2R8 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27715501 | 0.87 | GABRP (0.48) | FFAR4FFAR1AKR1B1FFAR3HDAC3 | |
| SCHEMBL9517412 | 0.81 | AKR1B1 (0.44) | FFAR4FFAR1AKR1B1GPR84PPARG | |
| SCHEMBL13869507 | 0.80 | TSHR (0.52) | PPARGPPARATSHRALDH1A1MEN1 | |
| SCHEMBL7888034 | 0.79 | THRB (0.40) | TSHRMEN1KMT2A | |
| SCHEMBL3820500 | 0.79 | GABRP (0.45) | FFAR4FFAR1AKR1B1GPR84PPARG | |
| SCHEMBL27961870 | 0.78 | CAMK2A (0.44) | FFAR4FFAR1GPR84TSHRALDH1A1 | |
| SCHEMBL6385659 | 0.78 | AKR1B1 (0.41) | FFAR4FFAR1AKR1B1GPR84PPARG | |
| SCHEMBL8673973 | 0.78 | AKR1B1 (0.41) | FFAR4FFAR1AKR1B1GPR84PPARG | |
| SCHEMBL28239013 | 0.78 | PAOX (0.39) | FFAR4FFAR1GPR84ALDH1A1 | |
| Stearic Acid SCHEMBL27604205 | 0.77 | GPR84 (0.61) | FFAR4FFAR1AKR1B1GPR84PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090130648-A1 | Oxidized Phospholipids | TECHNISCHE UNIVERSITÄT GRAZ (AT) | 2009-05-21 | — | — | US | disclosed |
| US-4680285-A | Treatment of malignant tumors with 2-(β-D-ribofuranosylthiazole-4-carboxamide related compounds | VIRATEK, INC. (US) | 1987-07-14 | — | — | US | disclosed |
| EP-0090405-B1 | NOVEL AZOLE DINUCLEOTIDE COMPOUNDS AND METHODS FOR THEIR PRODUCTION | BRIGHAM YOUNG UNIVERSITY (US) | 1986-06-25 | — | — | EP | disclosed |
| US-4594415-A | Viricides | ROBINS ROLAND K (US) | 1986-06-10 | — | — | US | disclosed |
| US-4544741-A | Azole dinucleotide compounds and methods for their production | BRIGHAM YOUNG UNIVERSITY, PROVO, UT., A NONPROFIT CORP. OF UT | 1985-10-01 | — | — | US | disclosed |
| EP-0090405-A1 | Novel azole dinucleotide compounds and methods for their production | BRIGHAM YOUNG UNIVERSITY (US) | 1983-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090130648-A1 | Oxidized Phospholipids | SGMS1, SGMS2, PHOSPHO1 | FFAR4 964/4885FFAR1 472/4885AKR1B1 1161/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.